Home
>
National Drug Code (NDC)
>
Depakote
Depakote - 21695-359-30 - (Divalproex sodium)
Drug Information of Depakote
| Product NDC: | 21695-359 |
| Proprietary Name: | Depakote |
| Non Proprietary Name: | Divalproex sodium |
| Active Ingredient(s): | 250 mg/1 & nbsp; Divalproex sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Depakote
| Product NDC: | 21695-359 |
| Labeler Name: | Rebel Distributors Corp |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021168 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100607 |
Package Information of Depakote
| Package NDC: | 21695-359-30 |
| Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (21695-359-30) |
NDC Information of Depakote
| NDC Code | 21695-359-30 |
| Proprietary Name | Depakote |
| Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (21695-359-30) |
| Product NDC | 21695-359 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Divalproex sodium |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20100607 |
| Marketing Category Name | NDA |
| Labeler Name | Rebel Distributors Corp |
| Substance Name | DIVALPROEX SODIUM |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |
